Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

The Socioeconomic Burden of Coronary Heart Disease in Korea

  • Chang, Hoo-Sun (Department of Preventive Medicine, Yonsei University College of Medicine) ;
  • Kim, Han-Joong (Department of Preventive Medicine, Yonsei University College of Medicine) ;
  • Nam, Chung-Mo (Department of Preventive Medicine, Yonsei University College of Medicine) ;
  • Lim, Seung-Ji (Health Insurance Policy Research Institute, National Health Insurance Corporation) ;
  • Jang, Young-Hwa (Institute of Health Services Research, Yonsei University College of Medicine) ;
  • Kim, Se-Ra (Health Insurance Review and Assessment Services) ;
  • Kang, Hye-Young (College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University)
  • Received : 2011.12.06
  • Accepted : 2012.06.07
  • Published : 2012.09.29
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: We aimed to estimate the annual socioeconomic burden of coronary heart disease (CHD) in Korea in 2005, using the National Health Insurance (NHI) claims data. Methods: A prevalence-based, top-down, cost-of-treatment method was used to assess the direct and indirect costs of CHD (International Classification of Diseases, 10th revision codes of I20-I25), angina pectoris (I20), and myocardial infarction (MI, I21-I23) from a societal perspective. Results: Estimated national spending on CHD in 2005 was $2.52 billion. The majority of the spending was attributable to medical costs (53.3%), followed by productivity loss due to morbidity and premature death (33.6%), transportation (8.1%), and informal caregiver costs (4.9%). While medical cost was the predominant cost attribute in treating angina (74.3% of the total cost), premature death was the largest cost attribute for patients with MI (66.9%). Annual per-capita cost of treating MI, excluding premature death cost, was $3183, which is about 2 times higher than the cost for angina ($1556). Conclusions: The total insurance-covered medical cost ($1.13 billion) of CHD accounted for approximately 6.02% of the total annual NHI expenditure. These findings suggest that the current burden of CHD on society is tremendous and that more effective prevention strategies are required in Korea.

Keywords

References

  1. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97(6):596-601.
  2. Lopez AD. Assessing the burden of mortality from cardiovascular diseases. World Health Stat Q 1993;46(2):91-96.
  3. Sekikawa A, Kuller LH, Ueshima H, Park JE, Suh I, Jee SH, et al. Coronary heart disease mortality trends in men in the post World War II birth cohorts aged 35-44 in Japan, South Korea and Taiwan compared with the United States. Int J Epidemiol 1999;28(6):1044-1049.
  4. Kesteloot H. Changes in all-cause and cardiovascular mortality rates in Eastern Europe: a missed opportunity. Acta Cardiol 2001;56(5):273-275.
  5. Khang YH, Lynch JW, Kaplan GA. Impact of economic crisis on cause-specific mortality in South Korea. Int J Epidemiol 2005; 34(6):1291-1301.
  6. Chun BY, Kim KB, Kim KS, Kim YJ, Kim YN, Kim CY, et al. The incidence rate of coronary heart disease in city area. Korean J Prev Med 1998;31(3):395-403 (Korean).
  7. Health Insurance Review Agency; National Health Insurance Corporation. 2005 National health insurance statistical yearbook. Seoul: Health Insurance Review Agency, National Health Insurance Corporation; 2006, p. 408-412 (Korean).
  8. Cheng Y, Chen KJ, Wang CJ, Chan SH, Chang WC, Chen JH. Secular trends in coronary heart disease mortality, hospitalization rates, and major cardiovascular risk factors in Taiwan, 1971-2001. Int J Cardiol 2005;100(1):47-52.
  9. Zethraeus N, Molin T, Henriksson P, Jonsson B. Costs of coronary heart disease and stroke: the case of Sweden. J Intern Med 1999;246(2):151-159.
  10. Liu JL, Maniadakis N, Gray A, Rayner M. The economic burden of coronary heart disease in the UK. Heart 2002;88(6):597-603.
  11. Rice DP, Hodgson TA, Sinsheimer P, Browner W, Kopstein AN. The economic costs of the health effects of smoking, 1984. Milbank Q 1986;64(4):489-547.
  12. Munk EM, Drewes AM, Gorst-Rasmussen A, Gregersen H, Funch- Jensen P, Norgard B. Risk of peptic ulcer, oesophagitis, pancreatitis or gallstone in patients with unexplained chest/epigastric pain and normal upper endoscopy: a 10-year Danish cohort study. Aliment Pharmacol Ther 2007;25(10):1203-1210.
  13. Sorensen HT, Horvath-Puho E, Lash TL, Christiansen CF, Pesavento R, Pedersen L, et al. Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis. Circulation 2011;124(13):1435-1441.
  14. Korea National Statistical Office. 2005 Cause of death statistics [cited 2012 Sep 15]. Available from: http://kosis.kr/abroad/abroad_01List.jsp?parentId=D (Korean).
  15. Ministry of Labor. 2005 Survey report on wage structure [cited 2012 Sep 15]. Available from: http://laborstat.moel.go.kr (Korean).
  16. Korea National Statistical Office. 2005 Cause of death statistics [cited 2012 Sep 15]. Available from: http://kosis.kr/abroad/abroad_01List.jsp?parentId=D (Korean).
  17. Drummmond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005, p. 78-88.
  18. Kang HY, Kang DR, Jang YH, Park SE, Choi WJ, Moon SH, et al. Estimating the economic burden of osteoporotic vertebral fracture among elderly Korean women. J Prev Med Public Health 2008;41(5):287-294 (Korean).
  19. No IC, Suh MH, Kim YL. Socioeconomic costs of alcohol and policy issues. Seoul: Korea Institute for Health and Social Affairs; 1997, p. 80-82 (Korean).
  20. Korea National Statistical Office. Life time table 2007; 2008 [cited 2012 Agu 30]. Available from: http://kostat.go.kr/portal/ korea/kor_nw/2/1/index.board?bmode= read&bSeq=&a Seq=65888&pageNo=1&rowNum=10&navCount=10&curr Pg=&sTarget= title&sTxt=%EC%83%9D%EB%AA%85%ED% 91%9C (Korean).
  21. Health Insurance Review and Assessment Service. Guidelines for economic evaluation of pharmaceuticals in Korea and data handling. Seoul: Health Insurance Review and Assessment Service; 2006, p. 33-34 (Korean).
  22. Jung YH, Ko S. Estimating socioeconomic costs of five major diseases. Korean J Public Finance 2004;18(2):77-104 (Korean).
  23. Lim SJ, Kim HJ, Nam CM, Chang HS, Jang YH, Kim S, et al. Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database. J Prev Med Public Health 2009;42(4):251-260 (Korean).
  24. Kim J, Hahm MI, Park EC, Park JH, Park JH, Kim SE, et al. Economic burden of cancer in South Korea for the year 2005. J Prev Med Public Health 2009;42(3):190-198 (Korean).
  25. Cheng A, Braunstein JB, Dennison C, Nass C, Blumenthal RS. Reducing global risk for cardiovascular disease: using lifestyle changes and pharmacotherapy. Clin Cardiol 2002;25(5):205-212.
  26. Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006;27(13):1610-1619.
  27. Luengo-Fernandez R, Leal J, Gray A, Petersen S, Rayner M. Cost of cardiovascular diseases in the United Kingdom. Heart 2006; 92(10):1384-1389.
  28. Ford ES, Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 2007;50(22): 2128-2132.
  29. Russell MW, Huse DM, Drowns S, Hamel EC, Hartz SC. Direct medical costs of coronary artery disease in the United States. Am J Cardiol 1998;81(9):1110-1115.
  30. Ramsey SD. How should we value lives lost to cancer? J Natl Cancer Inst 2008;100(24):1742-1743.
  31. Swahn E. The care of patients with ischaemic heart disease from a gender perspective. Eur Heart J 1998;19(12):1758-1765.
  32. Hemingway H, Langenberg C, Damant J, Frost C, Pyorala K, Barrett-Connor E. Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries. Circulation 2008;117(12):1526-1536.
  33. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986;111(2):383-390.
  34. Park BJ, Sung JH, Park KD, Seo SW, Kim SW. Report of the evaluation for validity of discharged diagnoses in Korean Health Insurance database. Seoul: Seoul National University; 2003 (Korean).
  35. Allender S, Scarborough P, Peto V, Rayner M, Leal J, Luengo- Fernandez R, et al. European cardiovascualr disease statitstics. Oxford: University of Oxford; 2008, p. 107.

Cited by

  1. The Economic Burden of Self-Reported and Undiagnosed Cardiovascular Diseases and Diabetes on Indonesian Households vol.9, pp.6, 2012, https://doi.org/10.1371/journal.pone.0099572
  2. The Incidence and Prevalence of Diabetes Mellitus and Related Atherosclerotic Complications in Korea: A National Health Insurance Database Study vol.9, pp.10, 2014, https://doi.org/10.1371/journal.pone.0110650
  3. Admission route and use of invasive procedures during hospitalization for acute myocardial infarction: analysis of 2007-2011 National Health Insurance database vol.37, pp.None, 2015, https://doi.org/10.4178/epih/e2015022
  4. Recent Trends in Economic Burden of Acute Myocardial Infarction in South Korea vol.10, pp.2, 2012, https://doi.org/10.1371/journal.pone.0117446
  5. Trends in lipid profiles among South Korean adults: 2005, 2008 and 2010 Korea National Health and Nutrition Examination Survey vol.37, pp.2, 2015, https://doi.org/10.1093/pubmed/fdu012
  6. Factors Predicting Nutrition and Physical Activity Behaviors Due to Cardiovascular Disease in Tehran University Students: Application of Health Belief Model vol.17, pp.3, 2012, https://doi.org/10.5812/ircmj.18879
  7. Productivity losses associated with cardiovascular disease: a systematic review vol.16, pp.6, 2012, https://doi.org/10.1080/14737167.2016.1259571
  8. Reference Values for The Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Non-High-Density Lipoprotein Cholesterol in Korean Children and Adolescents: The Korean National Health and Nutr vol.23, pp.12, 2012, https://doi.org/10.5551/jat.35634
  9. Sex differences in discharge destination following acute myocardial infarction vol.29, pp.6, 2012, https://doi.org/10.1097/mca.0000000000000643
  10. Socioeconomic Costs of Age-related Macular Degeneration in Korea vol.60, pp.8, 2012, https://doi.org/10.3341/jkos.2019.60.8.765
  11. Cost-Effectiveness Analysis for National Dyslipidemia Screening Program in Korea: Results of Best Case Scenario Analysis Using a Markov Model vol.29, pp.3, 2012, https://doi.org/10.4332/kjhpa.2019.29.3.357
  12. Association of Thyroid-Stimulating Hormone and Thyroid Hormones with Cardiometabolic Risk Factors in Euthyroid Children and Adolescents Aged 10-18 Years: A Population-Based Study vol.9, pp.1, 2012, https://doi.org/10.1038/s41598-019-51963-7
  13. Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea vol.15, pp.1, 2020, https://doi.org/10.1371/journal.pone.0228472
  14. Epidemiology of cardiovascular disease and its risk factors in Korea vol.3, pp.3, 2021, https://doi.org/10.35772/ghm.2021.01008
  15. Cost-Effectiveness Analysis of Positive Airway Pressure in Patient with Obstructive Sleep Apnea vol.28, pp.2, 2012, https://doi.org/10.18787/jr.2021.00357